The long version
At Americans for Responsible Innovation — now the largest AI policy advocacy organization in Washington — Satya served as Senior Vice President of Government Affairs, running the organization's AI policy strategy, including advocacy on the TAKE IT DOWN Act, now federal law, and the DEFIANCE Act, both targeting AI-generated deepfake abuse. The advocacy ran on coalitions he helped assemble — child-safety groups beside tech policy organizations, industry signatories beside university research labs.
At a Top 100 law firm, he advised clients in government relations, lobbying on behalf of Fortune 50 companies, tech startups, nonprofits, and clients under Congressional investigation. At EQRx, a multibillion-dollar, venture-backed biotech, he led policy as Senior Vice President. Having testified multiple times before the House and Senate, he is frequently called upon as a bipartisan expert witness and advisor in Congress.
As Senior Counselor in the White House, Satya oversaw rulemaking across nearly a dozen cabinet agencies, with a hand in the first-ever AI executive order and major export controls on dual-use technologies. In Congress he was the Senate point-person on regulatory reform, the Congressional Review Act, federal permitting reform, and government-wide initiatives like the Evidence-Based Policymaking Act. He wrote and negotiated the Right to Try Act and ran the political effort that passed it, a law name-checked in two State of the Union addresses and in a general-election presidential debate. During that time he was also a Bertelsmann Congressional European Parliamentary Initiative Fellow and a Fellow in Wilson Center AI and Cybersecurity labs, as well as Senate liaison to ACUS.
As the 2008 financial crisis unfolded, he founded the Financial Markets Working Group at George Mason University's Mercatus Center, work that earned the Atlas Network's Templeton Freedom Award. He was research faculty at the Antonin Scalia Law School at George Mason University, and did his doctoral work in economics at Emory University. He is currently an advisory board member at psychedelic medicine policy organizations Reason for Hope and the Psychedelic Medicine Coalition, as well as a board member at the Sebastiani Theatre Foundation.
LinkedIn
Full CV (PDF)
